Tarsons Products Q1 FY27 Revenue Up 21% to ₹110 Crore; Exports Grow 29%
Tarsons Products reported Q1 FY27 consolidated revenue of ₹110 crore, up 21% YoY, with standalone revenue at ₹86 crore, also up 21% YoY. Exports grew 29% YoY. Margins were impacted by raw material costs, but cash profit grew 18% YoY. New capacities are ramping up, expected to drive future growth.
The results show strong top-line growth and a positive outlook due to capacity expansions, but margin pressure from raw material costs and the impact of new facility ramp-up costs temper the immediate financial impact.
The company reported strong revenue growth in Q1 FY27, driven by both domestic and export segments. Despite margin pressures from raw material costs, cash profit showed healthy growth, and the company is well-positioned with its expanded capacities for future growth.
Tarsons Products Limited reported a robust performance for the first quarter of FY27, with consolidated revenue surging by 21% year-on-year to ₹110 crore. Standalone revenue also saw a significant jump of 21% year-on-year, reaching ₹86 crore, marking the highest-ever Q1 standalone revenue for the company. Domestic sales grew by 17% year-on-year, driven by an extensive distribution network and improving demand conditions across various industries.
The company's export business demonstrated a strong recovery, growing by 29% in the first quarter, following disruptions from geopolitical tensions and tariff uncertainties. Enhanced participation in international trade fairs and exhibitions has boosted visibility and customer engagement, leading to increased inquiries and order conversions. The white labeling segment is identified as a key future growth driver for exports.
Profitability in Q1 FY27 was impacted by a sharp escalation in raw material prices, with key input costs rising by 25% to 50%, which put pressure on gross margins. EBITDA was further affected by operating costs associated with recently commissioned facilities. To mitigate rising input costs, partial price increases were implemented, with full benefits expected to materialize with a one-quarter lag. Cash profit, however, showed resilience, growing 18% year-on-year to ₹25.6 crore on a consolidated basis.
Tarsons Products is in the final phase of its large-scale capacity expansion program, with substantial CAPEX commissioned and operational. The focus is now shifting towards capacity utilization and commercialization, with new facilities expected to contribute meaningfully from the second half of FY27 onwards. These investments are poised to enhance manufacturing capabilities and product breadth, positioning the company for sustainable revenue growth and improved profitability from FY28 onwards.
The company's German subsidiary also delivered a resilient performance, with revenue growing approximately 6% year-on-year in constant currency terms. Tarsons Products aims to leverage the Nerbe brand's network to cross-sell its own manufactured products, presenting a significant growth opportunity.
What to do with a filing like this
Tarsons Products Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tarsons Products Limited. Read the original for the full detail.